Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colitis | 6 | 2022 | 1238 | 1.780 |
Why?
|
Enterocolitis | 2 | 2024 | 106 | 1.590 |
Why?
|
Hepatitis | 3 | 2023 | 226 | 0.970 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 7 | 2016 | 388 | 0.950 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1205 | 0.890 |
Why?
|
Gastritis | 2 | 2022 | 199 | 0.860 |
Why?
|
Alanine Transaminase | 2 | 2024 | 609 | 0.810 |
Why?
|
Pancreatitis | 3 | 2024 | 1087 | 0.760 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 361 | 0.750 |
Why?
|
Gastrointestinal Tract | 2 | 2018 | 837 | 0.730 |
Why?
|
Methylprednisolone | 1 | 2021 | 386 | 0.690 |
Why?
|
DNA Glycosylases | 3 | 2020 | 125 | 0.650 |
Why?
|
Colitis, Microscopic | 1 | 2020 | 72 | 0.650 |
Why?
|
Colitis, Lymphocytic | 1 | 2019 | 23 | 0.640 |
Why?
|
Gastroparesis | 1 | 2020 | 143 | 0.600 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2024 | 2441 | 0.580 |
Why?
|
Education, Medical, Continuing | 1 | 2022 | 829 | 0.570 |
Why?
|
Melanoma | 3 | 2020 | 5702 | 0.550 |
Why?
|
Immunotherapy | 5 | 2022 | 4745 | 0.530 |
Why?
|
Mucous Membrane | 1 | 2019 | 659 | 0.500 |
Why?
|
Neoplasms | 9 | 2024 | 22350 | 0.480 |
Why?
|
Adenomatous Polyposis Coli | 3 | 2015 | 219 | 0.470 |
Why?
|
Intestinal Neoplasms | 2 | 2012 | 314 | 0.380 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2012 | 182 | 0.380 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 784 | 0.340 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10748 | 0.330 |
Why?
|
Diarrhea | 3 | 2022 | 1319 | 0.330 |
Why?
|
Genetic Testing | 5 | 2020 | 3591 | 0.330 |
Why?
|
Gastroenterology | 1 | 2016 | 593 | 0.320 |
Why?
|
Paracentesis | 1 | 2009 | 99 | 0.320 |
Why?
|
Colorectal Neoplasms | 5 | 2020 | 6966 | 0.300 |
Why?
|
Dysentery | 1 | 2007 | 14 | 0.290 |
Why?
|
Adenoma | 2 | 2020 | 2155 | 0.270 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2824 | 0.270 |
Why?
|
Hospitalization | 2 | 2024 | 10815 | 0.270 |
Why?
|
Vitamin D | 1 | 2020 | 3312 | 0.270 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2012 | 616 | 0.260 |
Why?
|
Retrospective Studies | 12 | 2024 | 81659 | 0.260 |
Why?
|
Catheterization, Peripheral | 1 | 2009 | 346 | 0.250 |
Why?
|
Intestine, Small | 1 | 2012 | 1217 | 0.250 |
Why?
|
Pancreatic Neoplasms | 2 | 2016 | 5446 | 0.250 |
Why?
|
Early Detection of Cancer | 3 | 2016 | 3236 | 0.250 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2007 | 264 | 0.240 |
Why?
|
Bismuth | 1 | 2024 | 28 | 0.240 |
Why?
|
Carcinoma | 1 | 2016 | 2326 | 0.230 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 537 | 0.230 |
Why?
|
Medical Oncology | 1 | 2016 | 2341 | 0.220 |
Why?
|
Radioimmunotherapy | 1 | 2023 | 93 | 0.210 |
Why?
|
Peutz-Jeghers Syndrome | 2 | 2016 | 61 | 0.210 |
Why?
|
Middle Aged | 20 | 2024 | 223233 | 0.210 |
Why?
|
Liver | 1 | 2018 | 7578 | 0.200 |
Why?
|
Educational Measurement | 1 | 2009 | 1259 | 0.200 |
Why?
|
Humans | 39 | 2024 | 767040 | 0.200 |
Why?
|
Internal Medicine | 1 | 2009 | 1064 | 0.200 |
Why?
|
Glucocorticoids | 2 | 2022 | 2163 | 0.200 |
Why?
|
Lymphadenitis | 1 | 2022 | 99 | 0.190 |
Why?
|
Helicobacter pylori | 1 | 2024 | 380 | 0.180 |
Why?
|
Helicobacter Infections | 1 | 2024 | 390 | 0.180 |
Why?
|
Medical History Taking | 1 | 2004 | 779 | 0.180 |
Why?
|
Pancreatitis, Chronic | 2 | 2016 | 282 | 0.180 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2020 | 93 | 0.170 |
Why?
|
Liver Function Tests | 1 | 2021 | 526 | 0.170 |
Why?
|
Genes, APC | 1 | 2020 | 144 | 0.170 |
Why?
|
Immune System Diseases | 1 | 2022 | 253 | 0.170 |
Why?
|
Jews | 1 | 2020 | 359 | 0.150 |
Why?
|
International Classification of Diseases | 1 | 2024 | 935 | 0.150 |
Why?
|
Female | 22 | 2024 | 396660 | 0.150 |
Why?
|
Aged | 13 | 2024 | 171319 | 0.150 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6360 | 0.150 |
Why?
|
Gastric Emptying | 1 | 2020 | 247 | 0.150 |
Why?
|
Adult | 14 | 2024 | 223317 | 0.150 |
Why?
|
Anti-Bacterial Agents | 2 | 2024 | 7469 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2020 | 1885 | 0.140 |
Why?
|
Education, Medical, Graduate | 1 | 2009 | 2420 | 0.140 |
Why?
|
Male | 19 | 2024 | 364203 | 0.140 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 1987 | 0.130 |
Why?
|
Abdominal Pain | 1 | 2022 | 1069 | 0.130 |
Why?
|
Drug Resistance | 1 | 2021 | 1592 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2016 | 100 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2016 | 3552 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2009 | 4054 | 0.120 |
Why?
|
Prognosis | 3 | 2024 | 29963 | 0.110 |
Why?
|
Feces | 1 | 2020 | 1508 | 0.110 |
Why?
|
Clinical Competence | 1 | 2009 | 4859 | 0.110 |
Why?
|
Genetic Counseling | 2 | 2009 | 635 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1883 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7236 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8628 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2605 | 0.100 |
Why?
|
Endosonography | 1 | 2016 | 626 | 0.100 |
Why?
|
Mutation | 2 | 2015 | 30211 | 0.090 |
Why?
|
Risk Assessment | 4 | 2021 | 24299 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2016 | 1788 | 0.090 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 59 | 0.090 |
Why?
|
Colonic Neoplasms | 1 | 2022 | 2535 | 0.090 |
Why?
|
Liver Diseases | 1 | 2018 | 1304 | 0.080 |
Why?
|
Internship and Residency | 1 | 2009 | 5947 | 0.080 |
Why?
|
Pedigree | 2 | 2009 | 4539 | 0.080 |
Why?
|
Phenotype | 3 | 2020 | 16718 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3779 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2024 | 4881 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59548 | 0.070 |
Why?
|
Benzamides | 1 | 2012 | 1376 | 0.070 |
Why?
|
DNA Mismatch Repair | 1 | 2009 | 431 | 0.070 |
Why?
|
Intestinal Fistula | 1 | 2007 | 146 | 0.060 |
Why?
|
Pyrroles | 1 | 2012 | 1122 | 0.060 |
Why?
|
Disease Progression | 1 | 2022 | 13646 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15851 | 0.060 |
Why?
|
Colonic Diseases | 1 | 2007 | 204 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2381 | 0.060 |
Why?
|
Rifabutin | 1 | 2024 | 53 | 0.060 |
Why?
|
Colonoscopy | 2 | 2010 | 1409 | 0.060 |
Why?
|
Logistic Models | 3 | 2010 | 13284 | 0.060 |
Why?
|
Clarithromycin | 1 | 2024 | 87 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4114 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1836 | 0.050 |
Why?
|
Risk | 1 | 2016 | 9606 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9245 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 26325 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15925 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5389 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2548 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4780 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4892 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13650 | 0.050 |
Why?
|
Mass Screening | 2 | 2010 | 5456 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6215 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9362 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2007 | 1472 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2902 | 0.040 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 945 | 0.040 |
Why?
|
Drug Resistance, Bacterial | 1 | 2007 | 1063 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3044 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11872 | 0.040 |
Why?
|
Proton Pump Inhibitors | 1 | 2024 | 551 | 0.040 |
Why?
|
Adolescent | 3 | 2021 | 89046 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4256 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2020 | 13491 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2024 | 1202 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6310 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 18063 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13485 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 59980 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2020 | 65295 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12986 | 0.030 |
Why?
|
Triage | 1 | 2020 | 995 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3621 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 15424 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 7435 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2004 | 3618 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20169 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2004 | 12069 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6777 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1903 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9660 | 0.020 |
Why?
|
Heterozygote | 1 | 2015 | 2794 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7446 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5924 | 0.020 |
Why?
|
Risk Factors | 2 | 2010 | 74886 | 0.020 |
Why?
|
Alleles | 1 | 2015 | 6893 | 0.010 |
Why?
|
Patient Compliance | 1 | 2010 | 2697 | 0.010 |
Why?
|
Population Surveillance | 1 | 2010 | 2594 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41718 | 0.010 |
Why?
|
United States | 1 | 2010 | 72971 | 0.000 |
Why?
|
Concepts
(167)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_